{
  "trial_id": "NCT02866240",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "9 years old or older",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "An established diagnosis of medically-refractory neocortical epilepsy",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Diagnosis of epilepsy with focal seizures with or without secondary generalization (International League Against Epilepsy classification)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Continued seizures despite adequate dosage in trials of at least 2 or more antiepileptic medications within approximately the last 3 years",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "At least one clearly identified and localizable epileptogenic zone from which 80% or more seizures arise",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Currently on 1-4 anti-epileptic drugs (AEDs) with no changes in antiepileptic drug doses in the 3 weeks prior to enrollment in the study and no planned dose changes during the trial and through the primary endpoint",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "A clinical or research MRI scan that is suitable for navigated brain stimulation (NBS) and generation of electrical fields",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "A reported average of at least 3 seizures per month (focal or secondarily generalized) over the three months prior to enrollment, and a minimum of 4 seizures recorded during the 8-week baseline period, with no 21-day seizure-free period during the 8 week baseline",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Written informed consent (and assent when applicable) obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Pregnant, breastfeeding, or unwilling to practice birth control during participation in the study",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has history of severe intellectual disability, CHF, and epilepsy. He has had seizures since age 13 and was recently tapered off Dilantin. The patient's MRI shows atrophic changes in the left temporal lobe.",
  "_meta": {
    "topic_id": "9",
    "trial_id": "NCT02866240",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}